Walgreens Boots Alliance Q4 sales rose 2.3% to $34.7 billion year-over-year basis, according to press release. Operating income declined 26.0% to 650 million while adjusted operating income was down 27.7% to $1.1 billion, a 27.4% fall on a constant currency basis. Earnings per share (EPS) declined 42.8% to $0.43 while adjusted EPS fell 28.2% to $1.02, a decrease of 27.9% on a constant currency basis.
- Walgreens fiscal 2021 guidance estimates low single-digit growth in adjusted EPS at constant currency rates.
- Company anticipates a gradual reduction in COVID-19 impacts; the first half results will continue to be adversely impacted.
- For the second half, Walgreens anticipates strong adjusted EPS growth as the recovery in key markets continues.
- Significant investments in fiscal 2021 to accelerate customer-centric approach to transforming omnichannel capabilities and offerings across retail and healthcare.
- Company sees gradual improvements in key U.S. and U.K markets and strong performance in wholesale business amid COVID-19 pandemic impacts.
- Company’s pharmacy-centered business is at the heart of community healthcare, and Walgreens will expand it in the future.
Walgreens stock rising on guidance outlook. WBA: NASDAQ is up 2.41%